drugset / Trial / NCT00492726

Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

NCT00492726

Phase 3 Completed 804 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to compare the safety and efficacy of moxifloxacin to ertapenem in patients with intra-abdominal infections.

Timeline

Start
2006-07
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ertapenem Small molecule 1 g Intravenous
Subject Moxifloxacin Small molecule 400 mg Intravenous

Indications